Two Bear Capital

Venture firm

Two Bear Capital investment thesis

Abilita Therapeutics Abilita Therapeutics enables discovery of novel therapeutics for previously undruggable membrane protein targets. Abilita Therapeutics enables discovery of novel therapeutics for previously undruggable membrane protein targets. About the company Abilita Therapeutics on LinkedIn Abilita Therapeutics website Abilita Therapeutics is a biotech company specializing in discovering and developing therapies for the most challenging membrane proteins, including GPCRs, ion channels and transporters. Despite their high significance, hundreds of such drug targets remain untapped. Abilita’s unique strength lies in generating transformative, whole-protein antigens through the Enabled Membrane Proteins (EMP™) platform, a proprietary directed evolution approach that swiftly creates en

Two Bear Capital team (11)

Partners and principals at Two Bear Capital:

Two Bear Capital portfolio companies

Companies listed on Two Bear Capital's public materials include: Skip to main content, Our Story, Our Focus, Our Portfolio, Work With Us, Pitch Us, Abilita Therapeutics, Arch Systems, Binarly, CIQ, Conceal, Dymium, Elisity, Fyr Bio, Graphiant, Gravwell, Inimmune, Leapfrog Bio, Montara Therapeutics, Novoron, PulseData, QuSecure, Rainfall Health, Revenium, Sanavia Oncology, Selector, Talus Bio, TileDB, View our focus areas, Two Bear Capital on LinkedIn, Explore, Offices, Whitefish, Menlo Park, San Diego, Boston, New York, Legal, About the company, Abilita Therapeutics on LinkedIn, Abilita Therapeutics website, Two Bear team, Mike Goguen, Jenna Aronson, PhD, Open roles, browse open roles across the portfolio, Go Back to portfolio, Arch Systems on LinkedIn, Arch Systems website, Jeff Miller.

Is Two Bear Capital a fit for your round?

Upload your pitch deck and see whether anyone at Two Bear Capital appears in your top matches.

Find investors for your deck